? ? Oxidant stress accompanies allergic inflammation in the asthmatic airway. Our central hypothesis is that asthmatic inflammation is mediated in part by this oxidant stress which is in turn regulated by the genetically determined expression of antioxidant enzymes and by dietary antioxidants. Polymorphisms of the glutathione S transferase (GSTP1) gene predict airway hyperreactivity, asthma, and atopy. GSTP1 is a multifunctional enzyme expressed in airway epithelium which detoxifies a variety of lipid and DNA products of oxidative stress and possesses selenium-independent peroxidase activity. To test our hypothesis we propose performing a series of experiments in genetically characterized human atopic asthmatics using well established models of allergic airway inflammation provoked by local or inhaled allergen challenge. Measurement of isoprostanes, the free radical-generated products of lipid peroxidation, will be employed throughout the experiments to monitor oxidant stress in vivo. In the first specific aim, we will determine if the genetic variants of GSTP1 differentially regulate oxidant stress caused by allergen in the airways. In the second specific aim we will establish the dose and time of treatment with vitamin E necessary to suppress oxidative stress in the airways. With this important information we will determine if supplementation with vitamin E modulates nonspecific airway hyperresponsiveness and allergen induced bronchospasm in allergic asthma. The question connecting the two specific aims will be whether vitamin E exerts different roles in individuals with various genetic variants of the GSTP1.These studies should provide important information about complex interactions between oxidative stress, and the critical components of the antioxidant defenses in allergic asthma. Understanding of the role of antioxidant vitamins in asthmatic inflammation is essential for their appropriate utilization in asthmatics. The study will stimulate future research on new prophylactic and treatment methods focused on antioxidant agents. The candidate's proposed career development plan includes advanced training in molecular and clinical genetics, biostatistics, advanced methods of study design and analysis, and research project administration through laboratory and clinical training, course work, and independent reading. Along with his record of publications and achievement, he will have rich academic surroundings, excellent mentors, and strong institutional commitment to ensure that he accomplishes his goals. (End of Abstract) ? ? ? ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
1K23HL080030-01A1
Application #
7024777
Study Section
Special Emphasis Panel (ZHL1-CSR-M (O1))
Program Officer
Rothgeb, Ann E
Project Start
2006-03-01
Project End
2010-02-28
Budget Start
2006-03-01
Budget End
2007-02-28
Support Year
1
Fiscal Year
2006
Total Cost
$152,253
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Sebag, Sara C; Koval, Olha M; Paschke, John D et al. (2017) Mitochondrial CaMKII inhibition in airway epithelium protects against allergic asthma. JCI Insight 2:e88297
Polosukhin, V V; Polosukhin, I V; Hoskins, A et al. (2014) Glutathione S-transferase M1 modulates allergen-induced NF-?B activation in asthmatic airway epithelium. Allergy 69:1666-72
Hoskins, Aimee; Reiss, Sara; Wu, Pingsheng et al. (2013) Asthmatic airway neutrophilia after allergen challenge is associated with the glutathione S-transferase M1 genotype. Am J Respir Crit Care Med 187:34-41
Greenwald, Roby; Johnson, Brent A; Hoskins, Aimee et al. (2013) Exhaled breath condensate formate after inhaled allergen provocation in atopic asthmatics in vivo. J Asthma 50:619-22
Sanders, Philip N; Koval, Olha M; Jaffer, Omar A et al. (2013) CaMKII is essential for the proasthmatic effects of oxidation. Sci Transl Med 5:195ra97
Hoskins, A; Wu, P; Reiss, S et al. (2013) Glutathione S-transferase P1 Ile105Val polymorphism modulates allergen-induced airway inflammation in human atopic asthmatics in vivo. Clin Exp Allergy 43:527-34
Hoskins, Aimee; Roberts 2nd, Jackson L; Milne, Ginger et al. (2012) Natural-source d-?-tocopheryl acetate inhibits oxidant stress and modulates atopic asthma in humans in vivo. Allergy 67:676-82
Dworski, Ryszard; Simon, Hans-Uwe; Hoskins, Aimee et al. (2011) Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. J Allergy Clin Immunol 127:1260-6
Dworski, Ryszard; Han, Wei; Blackwell, Timothy S et al. (2011) Vitamin E prevents NRF2 suppression by allergens in asthmatic alveolar macrophages in vivo. Free Radic Biol Med 51:516-21
Rock, Michael; Yoder, Sandra; Hoskins, Aimee et al. (2009) Effect of allergen challenge on the percentage of natural killer T cells in patients with atopic asthma. Ann Allergy Asthma Immunol 102:432-7